FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new pyrrolidine derivatives of general formula (1) 
or its pharmaceutically acceptable salts where R101 and R102 values are described by the patent claim. The compounds inhibit serotonin and/or norepinephrine and/or dopamine reabsorption thereby allowing to be used for treating depression and anxiety disorder. A method for preparing thereof is described.
EFFECT: preparation of new pyrrolidine derivatives.
10 cl, 162 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS EFFECTIVE AS MONOAMINE REUPTAKE INHIBITORS | 2006 |
|
RU2574406C2 |
| CARBOSTYRIL COMPOUND | 2005 |
|
RU2430920C2 |
| N-PYRIDIN-3-YL OR N-PYRAZIN-2-YL CARBOXAMIDES AS AGENTS INCREASING LEVEL OF HDLP CHOLESTEROL | 2011 |
|
RU2540069C2 |
| PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF BRAIN DAMAGE | 2018 |
|
RU2797548C2 |
| NEW AMINOPYRIDIN DERIVATIVE WITH INHIBITION ACTIVITY IN RELATION TO SYK | 2006 |
|
RU2363699C2 |
| SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINEAMIDES AND THEIR DERIVATIVES, METHODS OF TREATMENT OF PATIENTS AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2143424C1 |
| AZABICYCLOOCTANE DERIVATIVES, METHOD FOR PREPARING AND USING AS DIPEPTIDYL PEPTIDASE IV INHIBITORS | 2007 |
|
RU2447063C2 |
| NOVEL PYRIMIDINIMIDAZOLAMINES AS MODULATORS OF KINASE ACTIVITY | 2015 |
|
RU2690679C2 |
| PHENOXY-SUBSTITUTED PYRIMIDINES FOR APPLICATION AS OPIOID RECEPTOR MODULATORS | 2010 |
|
RU2554870C2 |
